23^rd International Conference on
Nephrology and Urology

Laurent Metzinger has completed his PhD in Biological Sciences and Pharmaceutical studies in Strasbourg, France and was a postdoctoral fellow from the University of Oxford (UK) in a leading lab on Duchenne muscular Dystrophy (Pr. Kay Davies). He works on microRNA regulation in the HEMATIM team in Amiens, and focuses on anemia and related vascular disorders associated with Chronic Kidney DIsease. He has authored some of the first papers showing a role for microRNAs in CKD and published in reputed journals, including Nature and Cell. He teaches Biochemistry, Genetics and Molecular Biology in the Pharmacy School of Amiens (University of Picardie Jules Verne).

General Nephrology, Kidney Transplantation, Diabetic Kidney Disease, Diabetes Prevention, including Weight Loss

Rajinder Yadav is the Director and Head of the Department of Urology, Andrology, Reconstructive Surgery, Laparoscopic Surgery, Genito-Uro-Onco Surgery, Renal Transplant & Robotic Surgery at Fortis Hospital Shalimar Bagh & Fortis Gurgaon, India Abstract: Urologists are much familiar with operating renal stones in normally located well ascended retroperitoneal kidneys. However operating on a renal stone in an anomalous pelvic dystopic kidney is a challenge. A multitude of treatment options are available for renal lithiasis like open surgery, ESWL, PCNL, Laparoscopy, RIRS. Conventional PCNL cannot be easily done in ectopic pelvic kindney because of overlying bone and risk of injuring bowel and anomalous blood supply of low lying kidney. An ectopic pelvic kidney can be safely dealt with various Laparoscopic techniques without any major complications. The first report of laparoscopic pyelolithotomy for calculus removal in a pelvic kidney was reported by William et.al in 1996 in J.Urol. So far only few cases of Laparoscopic stone surgery for ectopic pelvic kideny have been reported

Laparoscopic stone surgery

Consultant Paediatrician (1992-2010); Clinical Director of Paediatrics (1992-1998); Medical Director of Bury NHS Trust (1998-2003); Board Member of National Patient Safety Agency UK (2001-2003) (Now part of NHS Improvement) National Adviser for National Clinical Assessment Service (2003-2015) (Now part of NHS Resolution); National Adviser for Paediatric Complaints (CHAI – now called Care Quality Commission); Medical Director of Wrightington, Wigan and Leigh FT (2010-2017); Senior Lecturer at Edgehill University. He was Twice nominated as the top 50 Influential/Pioneering BME leader 2013 and 2014. In 2017 he received Life Time achievement Award for work on Patient Safety Adviser to GMC, DOH, BMA, NCAS at various stages of my career on BME issues and inclusion and diversity.

Patient Safety

Lavinia Oltita Bratescu completed her Graduation at University of Medicine and Pharmacy from Timisoara, in Romania. From 2007, she worked as a Nephrologist at Sf. Pantelimon International Healthcare Systems Nephrology and Dialysis Medical Center, in Bucharest. From 2012, she became the Chief Physician of the same clinic. From January 2016, Dr. Lavinia Oltita Bratescu is Chief Physician at Diaverum Morarilor Nephrology and Medical Center in Bucharest, Romania. She completed her PhD in November 2013. Her PhD thesis entitled The role of iron and hepcidin in pathogenesis of anemia on hemodialysis patients. For the first time in a study (published in Journal of Renal Nutrition), hepcidin-25 was measured using a commercial competitive ELISA method. Also, Dr. Bratescu has participated in national and international nephrology conference as a speaker and as poster presenter

The role of iron and hepcidin in pathogenesis of anemia on hemodialysis patients

Dr Francisco Salcido-Ochoa studied Medicine in the National Autonomous University of Mexico. He did both his Master of Science (Immunology) and his PhD in Transplantation Tolerance and Immunoregulation at Imperial College London. He also worked in Internal Medicine at the Royal London and Barts Hospitals, obtaining his MRCP (UK). He did his specialisation in Nephrology at the Singapore General Hospital, where he worked for 10 years as a nephrologist. Currently, he is a nephrologist and transplant immunologist practicing at Francisco Kidney & Medical Centre in Singapore, focusing on general nephrology, kidney transplantation, diabetic kidney disease, diabetes prevention, including weight loss. Dr Francisco has several international publications and has been invited for several oral presentations in different countries including the UK, Mexico, Switzerland, Malaysia, Spain and Singapore.

General Nephrology, Kidney Transplantation, Diabetic Kidney Disease, Diabetes Prevention, including Weight Loss

Josep M. Campistol is currently the General Director of the Hospital Clinic of Barcelona, Spain, and former Medical Director of the same hospital as well as Director of the Clinical Institute of Nephrology and Urology (ICNU). He is also Professor of Medicine at the Nephrology Department of the University of Barcelona. He received his medical degree from the University of Barcelona in 1983, and completed his residency in internal medicine and, subsequently, his fellowship in renal medicine at the Hospital Clinic of the same institution. Following his training as a fellow in renal medicine at the University of Barcelona, Prof. Campistol continued his clinical work in renal transplantation within the Renal Transplant Unit at the Hospital Clinic. During this period, he also developed research interests into the pathogenesis of dialysis-related amyloidosis, and undertook a visiting Fulbright Scholarship at Boston University School of Medicine in Boston, MA, USA (1991 to 1992). His doctoral thesis (1990) was based on the Pathogenesis of dialysis amyloidosis and the role of lymphocytes on beta 2 microglobulin synthesis and dialysis membranes. Prof. Campistol has published more than 700 experimental and clinical papers in international peer reviewed journals. He is a member of many international transplant societies, on the editorial board of a number of major international transplant journals and a principal investigator in numerous clinical studies. His current research interests include the use of new immunosuppressive regimens in renal transplantation, mechanisms of allograft fibrosis and renal regenerative medicine.

The use of new immunosuppressive regimens in renal transplantation, mechanisms of allograft fibrosis and renal regenerative medicine.

Anil K Saxena have over 30 years of experience in Clinical Nephrology including Hemodialysis, Peritoneal dialysis and follow up of renal transplantation and over 20 years of experience in conducting clinical research and publications including four randomised clinical trials on Hemodialysis catheter lock prophylaxis published in reputed Indexed International medical Journals. Published over 75 scientific papers till date. He is the Senior Scientific Advisor at CORMEDIX Incorporation, NJ, USA over 2 years and Member of Editorial Board of The Open Nephrology and Urology Journal, Wake forest university, North Carolina,USA, Member Of National Editorial Board of Saudi Journal of Kidney diseases and Transplantation (SJKDT), Member Of Editorial Board of World Journal of Clinical Urology (WJCU), Beijing,China., Member of Editorial Board of World Journal of Nephrology(WJN), Beijing, China, Member of Editorial Board of Case Reports In Nephrology (CRIN), Hindawi Publications., Member Of ASN (American Society of Nephrology), Fellow of Royal College of Physicians of Ireland, FRCPI, Fellow Of ASN (American Society of Nephrology), FASN, Expert peer reviewer for KI, AJKD, NDT, Hemodialysis International, AJIC, Nephrology, SJKDT

Clinical Nephrology including Hemodialysis, Peritoneal dialysis and renal transplantati

YOUSSEF EL GAMMAL was born in TANTA – EGYPT and completed his higher education in TANTA faculty of medicine, ROYAL college of surgeon, LONDON, EDINBURGH UK, and MD in NIXON university - USA. He had been brilliant in his educational career and contributed a lot to success in his professional life. He is a physician doctor UROLOGIST and NEPHROLOGIST. He worked as a medical INTERN, SHO, SPECIALIST and CONSULANT in TANTA uni., TOLLAMOR general hospital – DUBLIN, royal hospital -SHARJAH -UAE and AJMAN speciality general hospital -UAE.,He have achieved many things as urologist and nephrologist and received many awards for his great contribution in publishing papers (e.g. a paper in XX11 congress of the EDTA-ERA about CAPD). He is the inspiration to many.

Nephrology and Artificial Kidney

Omotayo Akinremi, a young Nigerian lady who resides in Nigeria, is the founder of Omotayo Kidney Care Foundation, an NGO outfit that takes health screening focused on hypertension, diabetes and kidney diseases to the community, majority of whom don’t have access to these important health care services. . The first child in a family of four and born in 1989, she is a Registered Nurse and also obtained Nephrology Nurse certificate from the School of Nephrology Nursing, National hospital, Abuja in 2014. In may year 2017, she was appointed as the head of the department (HOD) of dialysis unit at Garki Hospital Abuja, Federal Capital Territory, Nigeria. Where she has had the opportunity of interacting with more renal patients at the immediate environs, and in some other hospitals in Nigeria through the heads of the renal units monthly meetings thus enabling her to know the challenges attending care of patients and treatments of kidney diseases across different population groups. She has attended many conferences on nephrology, contributing and learning more about the best practices in the care and treatment of people living with kidney diseases.

Raising awareness on chronic kidney disease Educating the public on the importance, and the care of the kidneys with aim of providing primary prevention